TS8117253883	sideeffect 20 58	food-drug pharmacokinetic interactions
TS6317253883	drug 90 101	repaglinide
TS7017253883	drug 106 117	nateglinide
TS817253883	sideeffect 187 209	food-drug interactions
TS3417253883	drug 215 226	repaglinide
TS6217253883	drug 231 242	nateglinide
TS7417253883	drug 255 266	meglitinide
TS6917253883	drugEffect 332 359	improving insulin secretion
TS117253883	treatedDisease 377 401	type 2 diabetes mellitus
TS5917253883	treatedDisease 534 549	type 2 diabetes
TS4717253883	drug 566 579	sulfonylureas
TS1617253883	drugEffect 633 671	control of postprandial hyperglycaemia
TS6017253883	sideeffect 695 710	adverse effects
TS2117253883	sideeffect 721 734	hypoglycaemia
TS5317253883	sideeffect 817 830	renal failure
TS8617253883	mealTime 843 862	meal-related timing
TS3017253883	food 924 928	food
TS4017253883	mealTime 933 937	meal
TS2017253883	drugEffect 959 974	bioavailability
TS4117253883	food 1013 1017	food
TS1817253883	food 1040 1056	grapefruit juice
TS8017253883	sideeffect 1069 1097	pharmacokinetic interactions
TS8717253883	sideeffect 1204 1232	pharmacokinetic interactions
TS917253883	drug 1259 1270	repaglinide
TS5817253883	drug 1305 1316	nateglinide
TS1717253883	drug 1398 1409	metabolites
TS8917253883	sideeffect 1489 1517	pharmacokinetic interactions
TS9017253883	sideeffect 1540 1562	drug-drug interactions
TS8317253883	drug 1735 1756	lipid-lowering agents
TS4817253883	drugEffect 1821 1834	plasma levels
TS3717253883	sideeffect 1847 1879	deterioration of glucose control
TS4917253883	drugEffect 1918 1931	plasma levels
TS6817253883	sideeffect 1943 1956	hypoglycaemia
TS1017253883	sideeffect 2050 2058	toxicity
TS8217253883	sideeffect 2067 2095	Pharmacokinetic interactions
TS2217253883	drug 2174 2185	repaglinide
TS5217253883	drug 2196 2207	nateglinide
TS717253883	drug 2223 2231	rifampin
TS3117253883	drug 2242 2253	repaglinide
TS3217253883	drug 2336 2347	nateglinide
TS4217253883	drug 2476 2487	repaglinide
TS6417253883	drug 2502 2513	ciclosporin
TS6617253883	drug 2523 2534	gemfibrozil
TS2417253883	drug 2549 2560	nateglinide
TS1117253883	drug 2563 2574	Ciclosporin
TS517253883	drug 2593 2604	repaglinide
TS3317253883	sideeffect 2721 2748	pharmacokinetic interaction
TS2317253883	drug 2794 2805	gemfibrozil
TS6717253883	drug 2817 2833	CYP2C8 inhibitor
TS2517253883	drug 2840 2851	repaglinide
TS2617253883	drug 2873 2884	repaglinide
TS6517253883	treatedDisease 2950 2965	type 2 diabetes
T1	drug 68 89	insulinotropic agents
T2	drug 297 305	glinides
R1	has_effect Arg1:T2 Arg2:TS6917253883	
R2	treat Arg1:T2 Arg2:TS117253883	
T3	drug 487 512	antihyperglycaemic agents
T4	modeadm 482 486	oral
R3	treat Arg1:T3 Arg2:TS5917253883	
T5	drug 582 590	glinides
R5	has_effect Arg1:T5 Arg2:TS1617253883	
R6	has_effect Arg1:TS4717253883 Arg2:TS1617253883	
R7	has_sideeffect Arg1:T5 Arg2:TS2117253883	
R8	has_sideeffect Arg1:TS4717253883 Arg2:TS2117253883	
T6	drug 884 892	glinides
R9	increase_side_effect Arg1:TS1817253883 Arg2:TS8017253883	
T7	drug 1108 1116	glinides
T8	drug 1589 1597	glinides
T9	drug 1644 1667	glucose-lowering agents
T10	drug 1813 1820	glinide
T11	drug 1910 1917	glinide
R4	has_sideeffect Arg1:T10 Arg2:TS3717253883	
R10	has_sideeffect Arg1:T11 Arg2:TS6817253883	
T12	drug 2210 2220	Rifampicin
